Renaissance Series - PATIENTCENTRICITY: defining our role

October, 06 2016

PATIENTCENTRICITY: defining our role

One-day Thought Leadership Forum

4th November 2016, The Museum of Science, Boston

In this meeting designed for Senior Pharmaceutical Executives across disciplines, Adelphi invites you to engage in thought leading debate on the role of the pharmaceutical industry in bringing the claim of “patientcentricity” to life
Hear the views of expert speakers from a physician, regulatory, patient and pharma perspective
Engage in informed discussion with the faculty and your peers from leading pharma companies

Expert Speakers

  • Danie du Plessis - SVP, Head Worldwide Med Affairs, GSK
  • John H. Powers - Professor of Clinical Medicine at George Washington University School of Medicine
  • Ashley F. Slagle - Principal, Scientific and Regulatory Consulting, Aspen Consulting
  • Andreas M. Pleil - Senior Director, Team Lead, Outcomes & Evidence Hematology, Global Health & Value, Pfizer, Inc.
  • Denise Globe - VP and Head of Health Economics & Outcomes Research, US Oncology CD&MA Health Economics, Novartis
  • Sarah Krug - Patient Advocate, Educator and Executive director Cancer 101

Click HERE To Register